David S. Smith is a corporate lawyer focusing on company formation and governance, financings, intellectual property transactions and regulatory matters for life sciences companies and investors. He is an authority on the legal issues surrounding the use of human biological materials and the commercial development of tissue- and cell-based technologies. David is a member of the board of the Foundation for Cell & Gene Medicine. He is a former officer of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) and TERMIS-Americas and has been elected a Fellow of TERMIS. He has previously served as a founding officer of and legal counsel for the Pittsburgh Tissue Engineering Initiative, Inc. (PTEI), and as a director of the Pennsylvania Biotechnology Association (now Life Sciences PA). David was a co-founder and member of the management team of TissueInformatics.Inc, a tissue-based bioinformatics company. He has served as a member of the boards of directors of Predictive Oncology, Inc. (NASDAQ: POAI) and Cvergenics, Inc., and a member of the Scientific Advisory Board of Clinical Cell Culture, Ltd. (now Avita Medical). He received a Director's Special Citation from the FDA Center for Devices and Radiological Health for his work as a member of the Agency-industry team engaged in developing an alternative medical device approval pathway.